June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that ... improve the early diagnosis and management of a wide range of debilitating ...

The INTERCEPT study is being funded to the tune of €38 million (nearly $40 million) over the next five years and is described ...

Discover how the Mediterranean diet benefits newly diagnosed Crohn’s disease patients by reducing inflammation and improving ...

There are many things you can do to live more comfortably and confidently with Crohn's. and incontinence. Here are 5 you can ...

Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...

Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...

Takeda is serving as the Industry Lead in the newly launched INTERCEPT project to identify predictive biomarkers for Crohn's ...

The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

Both Crohn’s disease and ulcerative colitis involve ... are common in IBD patients and can complicate the diagnosis and management of the condition. Symptoms of IBD can be varied and impact ...

Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to severely active Crohn's disease in the adult ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...